Healthcare -
Biotechnology - NASDAQ - US
$ 34.055
1.23 %
$ 14.8 B
Market Cap
17.83
P/E
RPRX - STOCK-BASED COMPENSATION
Stock-based Compensation RPRX - Royalty Pharma plc
2.34 M
LAST VALUE
3.93%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR